PCN191 Cost Associated with Implementation of CAR T-Cell Therapy for the Management of Hematologic Cancers in Canada.
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.282
https://www.valueinhealthjournal.com/article/S1098-3015(21)00499-X/fulltext
Title :
PCN191 Cost Associated with Implementation of CAR T-Cell Therapy for the Management of Hematologic Cancers in Canada.
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00499-X&doi=10.1016/j.jval.2021.04.282
First page :
Section Title :
Open access? :
No
Section Order :
10856